February 25, 2026 — RNews

#pneumococcal — Wednesday, February 25, 2026 (1 items)

hot top new

← prev day next day →

0

A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naive Adults 18-64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8. (academic.oup.com)

Scott PT … Platt HL Clinical Infectious Diseases 2026-02-25

#vaccination #clinical trial #immunogenicity #safety #pneumococcal